RCUS

Arcus Biosciences Inc. Common Stock (RCUS)

Stock · NYSE · Health Care

$29.21as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$22.29
Industry
Biotechnology: Pharmaceutical Preparations

Arcus Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • RCUS
    Arcus Biosciences Inc. Common Stock
    $29.21
    ▼ 4.51%
    Market cap $3.47BP/E
  • GPCR
    Structure Therapeutics Inc. American Depositary Shares
    $47.38
    ▼ 3.74%
    Market cap $3.44BP/E
    $18.26$94.9
  • ELVN
    Enliven Therapeutics Inc. Common Stock
    $57.82
    ▼ 4.43%
    Market cap $3.53BP/E
    $14.79$62.32
  • TLX
    Telix Pharmaceuticals Limited American Depositary Shares
    $11.28
    ▼ 0.84%
    Market cap $3.39BP/E
    $6.28$12.5
  • ALMS
    Alumis Inc. Common Stock
    $22.38
    ▼ 3.58%
    Market cap $3.33BP/E
    $3.76$31.35
  • ARQT
    Arcutis Biotherapeutics Inc. Common Stock
    $23.78
    ▼ 4.38%
    Market cap $3.24BP/E 113.86
    $15.1$31.77
  • NAMS
    NewAmsterdam Pharma Company N.V. Ordinary Shares
    $25.9
    ▼ 3.32%
    Market cap $3.21BP/E
    $23.05$42.21

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
114.53M
Total value held
$2.46B
Institutional holders
204
Top holders this quarter
  • Unknown31.42M
  • Unknown15.23M
  • Unknown6.09M
  • Unknown5.41M
  • Unknown5.03M
  • Unknown3.86M
  • Unknown3.78M
  • Unknown3.76M
  • Unknown3.01M
  • Unknown2.25M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.